1. ddobbs
  2. Quick Dip: Mindreading, pig flu, green fade, health care costs, and drug money in Vermont

Quick Dip: Mindreading, pig flu, green fade, health care costs, and drug money in Vermont

By ddobbs on April 23, 2009.

Reading the Mindreading Studies - Science Progress seeks a handle on fMRI hype, hope, and horizons

The evolving Swine Flu story [Effect Measure] The skinny on a scary run of deadly swine flu, from people who've been doing this a while.

Green Issues Fade Is green losing its lustre?

Eli Lilly Tops List of Drug-Company Pay to Vermont Docs Altogether, 78 drug companies spent just shy of $3 million dollars in payments to health professionals in Vermont last year. This is a state of about 600,000 people, and only a few thousand doctors. Payments to psychiatrists, for instance, totaled $479,306.19 -- an average of $43,573.29 per psychiatrist who received money.

It's an awfully small state. Through social and other connections I happen to know quite a psychiatrists. It's unsettling to be wondering which ones might be receiving this money without declaring it.

And Ezra Klein considers WHY AMERICAN HEALTH CARE COSTS SO MUCH: PART ONE and then again in PART 2.

Tags
economics
Healthcare policy
medicine
Pharma
psychiatry
Science
Science Policy
environmentalism
fmri
swine flu
economics
medicine
Pharma
psychiatry
Science Policy

More like this

Does your doctor get money from drug companies? You'll be able to check in 2014
One of the less-noticed provisions of the Affordable Care Act is a requirement that pharmaceutical companies report to the Department of Health and Human Services the gifts and other payments they give to doctors and teaching hospitals -- and that HHS in turn make that information available to the…
PhRMA Nixes Pens for Docs
Pens, pads, and other trinkets bearing prescription-drug logos have come to symbolize the extensive presence of pharmaceutical marketing in healthcare settings, but they may be on their way out. Pharmaceutical-industry trade association The Pharmaceutical Research and Manufacturers of America (…
The Doctors Aren't the Only Ones at Fault
Yesterday, The New York Times reported on the latest prominent medical doctor to be outed for not reporting the vast sums of money he was receiving from drug companies: One of the nation's most influential psychiatrists earned more than $2.8 million in consulting arrangements with drug makers from…
Doctor Payola
An article in today's New York Times shines some light on drug industry gifts to doctors. Pretty interesting stuff: Vermont officials disclosed Tuesday that drug company payments to psychiatrists in the state more than doubled last year, to an average of $45,692 each from $20,835 in 2005.…